Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.52 |
| ▸ | MMP13 | P45452 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 3/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.52 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.52 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.52 |
| ▸ | RAPGEF4 | Q8WZA2 | 6/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroxyamine SCHEMBL259333 | 0.93 | CA1 (0.54) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL23788 | 0.93 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL7930818 | 0.93 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL10846507 | 0.93 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| Ammonia Solution, Strong SCHEMBL5999943 | 0.93 | CA1 (0.58) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL2549047 | 0.91 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| Water SCHEMBL458685 | 0.91 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL28656334 | 0.91 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL9243736 | 0.91 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL28505545 | 0.91 | CA1 (0.56) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143292-B2 | N-Thio-anthranilamid compounds and their use as pesticides | BASF SE (DE) | 2012-03-27 | — | — | US | disclosed |
| US-8119568-B2 | 3-amino-1,2-benzisothiazole compounds for combating animal pest II | BASF SE (DE) | 2012-02-21 | — | — | US | disclosed |
| EP-1904475-B1 | N-THIO-ANTHRANILAMID COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2011-08-17 | — | — | EP | disclosed |
| US-20100009848-A1 | 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II | BASF SE (DE) | 2010-01-14 | — | — | US | disclosed |
| EP-2064196-A2 | 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II | BASF Aktiengesellschaft (DE) | 2009-06-03 | — | — | EP | disclosed |
| WO-2008090048-A2 | 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II | BASF SE (DE) | 2008-07-31 | — | — | WO | disclosed |
| EP-1904475-A1 | N-THIO-ANTHRANILAMID COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007006670-A1 | N-THIO-ANTHRANILAMID COMPOUNDS AND THEIR USE AS PESTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009848-A1 | 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II | BPNT1, BCAT1, TGFBR1 | CA1 995/4885CA2 838/4885MMP1 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.